Advertisements


Gemphire Therapeutics stock tumbles 17% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire Therapeutics" stock extends slide, plummets 39% premarket after trial halt

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire"s stock more than doubles on heavy volume after upbeat trial results

Shares of Gemphire Therapeutics Inc. more than doubled (up 142%) in active premarket trade Friday, after the biopharmaceutical company said a phase 2b trial for gemcabene, a treatment for severe hypertriglycer.....»»

Category: topSource: marketwatchJun 29th, 2018

Gemphire Therapeutics stock plunges after trial halted due to "unanticipated problems"

Shares of Gemphire Therapeutics Inc. plunged 17% toward a record low F.....»»

Category: topSource: marketwatchAug 10th, 2018

Spark Therapeutics stock plummets 28% premarket on hemophilia trial"s patient safety concerns

Spark Ther.....»»

Category: topSource: marketwatchAug 7th, 2018

Spark Therapeutics stock plummets 25% premarket on hemophilia trial"s patient safety concerns

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 7th, 2018

UPDATE: Cara Therapeutics stock surges 34% on news of positive results in trial of post-surgery pain treatment

Cara Therapeutics Inc. shares soared 34% in premarket trade Wednesday, after the company reported positive data in a Phase 2/3 trial of a t.....»»

Category: topSource: marketwatchJun 27th, 2018

Menlo Therapeutics" stock plunges over 50% after disappointing trial results

Shares of Menlo Therapeutics Inc. lost more than half their value in premarket trade Monday, after the biopharmaceutical company's skin condition treatment failed to meet its primary or key secondary efficacy endpoints. The phase 2 trial showed no stat.....»»

Category: topSource: marketwatchApr 9th, 2018

Redfin"s stock tumbles 16% premarket after Q2 results late Thursday

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchAug 10th, 2018

Gemphire Therapeutics announces termination of Phase 2a trial of gemcabene

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 10th, 2018

Illinois Tool Works" stock tumbles after earnings match, but profit and margin outlook cut

Shares of Illinois Tool Works Inc. dropped 5.6% in premarket trade Monday, after the industrial products and equipment ma.....»»

Category: topSource: marketwatchJul 23rd, 2018

KemPharm"s stock soars after ADHD drug trial meets primary endpoints

Shares of KemPharm Inc. shot up 13% in premarket trade Monday after the specialty pharmaceutical company said a trial of its treatment of ADHD in patients between the ages of 6 and 12 (KP415) met primary.....»»

Category: topSource: marketwatchJul 9th, 2018

Gemphire Therapeutics (GEMP) Gemcabene Indigo Phase 2 Trial Results - Slideshow

Gemphire Therapeutics (GEMP) Gemcabene Indigo Phase 2 Trial Results - Slideshow.....»»

Category: topSource: seekingalphaJun 29th, 2018

Why Gemphire Therapeutics Shares More Than Doubled

Gemphire Therapeutics shares more than doubled early on Thursday after the company announced results from a midstage trial for severe hypertriglyceridemia......»»

Category: blogSource: 247wallstJun 29th, 2018

Pain Therapeutics" stock plummets 70% after FDA advisory panel vote disappoints

Shares of Pain Therapeutics Inc. plummeted 70% toward a record low in premarket trade Wednesday, after a Food and Drug Administration advisory committee voted against the approval of Remoxy ER for the treatment of severe pain. .....»»

Category: topSource: marketwatchJun 27th, 2018

UPDATE: Summit Therapeutics shares plummet 77% after trial of DMD treatment fails to meet main goals

Summit Therapeutics plc shares plunged 77% in premarket trade Wednesday, after.....»»

Category: topSource: marketwatchJun 27th, 2018

Global Blood Therapeutics shares drop after late-stage data for sickle cell disease treatment

Global Blood Therapeutics Inc. shares dropped as much as 12% in premarket trade on Wednesday after the company reported results for a late-stage trial of sickle cell disease therapy, and said that it met with the U.S. Food and Drug Ad.....»»

Category: topSource: marketwatchJun 27th, 2018

Sarepta Gets Boost From Early Trial Results on Muscular Dystrophy Treatment

Sarepta Therapeutics Inc. gained about $2.5 billion of stock market value after an early stage trial of a gene therapy showed promise in its ability to treat patients with Duchenne muscular dystrophy......»»

Category: smallbizSource: wsjJun 19th, 2018

PagSeguro stock tumbles after announcement of follow-on offering

Shares of PagSeguro Digital Ltd. are down 11.3% in premarket trading Tuesday after the Brazilian payments company announced a follow-on offering. In a filing late Monday, PagSegu.....»»

Category: topSource: marketwatchJun 19th, 2018

Michaels Companies stock tumbles after same-store sales and outlook miss expectations

Shares of Michaels Companies Inc. tumbled 16% in premarket trade Thursday, after.....»»

Category: topSource: marketwatchJun 14th, 2018

Flex Pharma"s stock extends slide, plunges 67% premarket after ending phase 2 trial, cutting jobs

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchJun 13th, 2018